Impact of reverse redistribution of technetium-99m-sestamibi in acute phase on improvement of left ventricular function, brain natriuretic peptide levels, exercise capacity, and prognosis in patients with acute coronary syndrome
Not Applicable
- Conditions
- Acute coronary syndrome
- Registration Number
- JPRN-UMIN000032436
- Lead Sponsor
- Gifu Prefectural General Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who did not undergo ultrasound echocardiography, laboratory test, and cardiopulmonary exercise test
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Major cardiac events including all cause death, life-threatening arrhythmia, and heart failure requiring hospitalization
- Secondary Outcome Measures
Name Time Method Improvement of LV function, BNP levels, exercise capacity in chronic phase (approximately 3 month after ACS)